Dr. Rita S. Axelrod focuses her clinical research on the multidisciplinary management of thoracic and head and neck malignancies, with particular emphasis on combined modality therapy and supportive care.
She has co-authored numerous peer-reviewed publications on topics including the use of immune checkpoint inhibitors in combination with radiotherapy for locally advanced squamous cell carcinoma of the head and neck, as well as the impact of preoperative programmed death-1 (PD-1) or programmed death ligand-1 (PD-L1) inhibition on surgical complications in primary head and neck cancer.